Keywords: Hospira, Gemcitabine, Gemzar, Eli Lilly

Hospira gains US approval of solution version of gemcitabine injection

Article | 07 August 2011

Print This

US generic injectable drug leader Hospira (NYSE: HSP) says the US Food and Drug Administration has approved its gemcitabine injection, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in